Evidence map›Paper›PMID 26475503›Full record

ArticleJournal of diabetes and its complications

Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failure.

Kathleen Dungan, Philip Binkley, Kwame Osei

Open access · greenAbstract read
In one paragraph

Article in Journal of diabetes and its complications. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Kathleen DunganThe Ohio State University Division of Endocrinology, Diabetes & Metabolism, 1581 Dodd Drive, Columbus, OH 43210. Electronic address: Kathleen.dungan@osumc.edu.
Philip BinkleyThe Ohio State University Dorothy M. Davis Heart and Lung Research Institute, 244 Davis Heart & Lung Research Institute, 473 W. 12th Avenue, Columbus, OH 43210; The Ohio State University Division of Cardiovascular Medicine, 244 Davis Heart & Lung Research Institute, 473 W. 12th Avenue, Columbus, OH 43210.
Kwame OseiThe Ohio State University Division of Endocrinology, Diabetes & Metabolism, 1581 Dodd Drive, Columbus, OH 43210.
The Ohio State University · USLung Institute · US

Funding

University of Iowa Clinical and Translational Science Program (TL1)UL1RR025755 · NCRR · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2008 to 2011
$26.3M
Intensive glycemic control for congestive heart failure exacerbationK23DK080891 · NIDDK · OHIO STATE UNIVERSITY · PI DUNGAN, KATHLEEN MARIE · 2008 to 2012
$748k
Glycemic control and variability in congestive heart failure exacerbationR21DK081877 · NIDDK · OHIO STATE UNIVERSITY · PI DUNGAN, KATHLEEN MARIE · 2008 to 2009
$413k
NCRR NIH HHS UL1 RR025755NCRR NIH HHS UL1RR025755NIDDK NIH HHS K23 DK080891NIDDK NIH HHS K23DK080891NIDDK NIH HHS R21 DK081877NIDDK NIH HHS R21DK081877
6 · The paper itself

Abstract

aimsThe objective of this study is to assess hypoglycemia and glycemic variability (GV) in hospitalized patients with and without heart failure (HF) exacerbation.

methodsHospitalized patients with type 2 diabetes (T2D) with (N=35) or without (N=16) HF who had hyperglycemia or significant insulin use were included. Subjects underwent continuous glucose monitoring during algorithmic titration of basal bolus insulin.

resultsHF subjects had lower glucose coefficient of variation ([CV], 31±12 vs. 22±8.2, p=0.02), lower Low Blood Glucose Index (LBGI) and less hypoglycemia (25% vs. 2.6%, p=0.02), but similar mean glucose and glycemic lability index as non-HF subjects on day 1, but not on day 2. Sensor CV was correlated with hypoglycemia (ρ 0.32, p=0.02), HF status (ρ -0.35, p=0.013), T2D duration (ρ 0.29, p=0.04), insulin use prior to admission (ρ 0.42, p=0.002) and catecholamine levels. After controlling for differences in age, HbA1c, hypoglycemia, catecholamine levels, QT interval, and beta blocker use, only HF and diabetes duration or insulin use prior to admission were independent predictors of CV. HF had less robust associations with LBGI in multivariable models.

conclusionsHF is not associated with increased GV or hypoglycemia risk during initial titration of insulin. Further research is needed to determine prognostic implications.

Indexed as

AgedAlgorithmsBlood GlucoseDiabetes Mellitus, Type 2Diabetic CardiomyopathiesDrug MonitoringFemaleHeart FailureHospitals, UrbanHumansHyperglycemiaHypoglycemiaHypoglycemic AgentsInsulinLength of StayMaleBlood GlucoseHypoglycemic AgentsInsulinGlycemic variabilityHeart failureHospitalHypoglycemiaInsulin

Identifiers

PMID26475503
PMCPMC4698074
OpenAlexW1701170235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.